The case against epitope spread in experimental allergic encephalomyelitis

Immunological Reviews

Volumn 164, Issue , 1998, Pages 101-110

  Takács, Katalin ^a   Altmann, Daniel M ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EPITOPE; GAMMA INTERFERON;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RELAPSE; SPLEEN; T LYMPHOCYTE;

ANIMALS; CENTRAL NERVOUS SYSTEM; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EPITOPES; MICE; PERIODICITY; RECURRENCE; SPLEEN;

EID: 0031785619     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1998.tb01212.x     Document Type: Article

References (40)

1. Martin R, McFarland HF, McFarlin DE. Immunological aspects of demyelinating diseases. Annu Rev Immunol 1995;10:1153-1187.
2. Kennedy M, Torrance DS, Picha KS, Mohler KM. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol 1992;149:2496-2505.
3. Merril JE, Kono DH, Clayton J, Ando DG, Hinto DR, Hofman FM. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc Natl Acad Sci USA 1992;89:574-578.
4. Issazadeh S, et al. Interferon γ, interleukin 4 and transforming growth factor β in experimental autoimmune encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells. J Neurosci Res 1995;40:579-590.
5. Perry LL, Barzaga ME. Kinetics and specificity of T and B cell responses in relapsing experimental allergic encephalomyelitis. J Immunol 1987;138:1434-1441.
6. McCarron RM, Fallis RJ, McFarlin DE. Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis. J Neuroimmunol 1990;29:73-79.
7. Perry LL, Barzaga-Gilbert E, Trotter J. T-cell sensitization to proteolipid protein in myelin basic protein induced experimental allergic encephalomyelitis. J Neuroimmunol 1991;33:7-16.
8. Cross AH, Tuohy VK, Raine CS. Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination. Cell Immunol 1993;146:261-269.
9. Lehmann PV, Forsthuber T, Miller A, Sercarz EE. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992;358:155-157.
10. Jansson L, Diener P, Engstrom A. Olsson T, Holmdahl R. Spreading of the immune response to different myelin basic protein peptides in chronic experimental autoimmune encephalomyelitis in B10.RIII mice. Eur J Immunol 1995;25:2195-2200.
11. McRae BL, Vanderlugt CL, Dal Canto MC, Miller SD. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J Exp Med 1995;182:75-83.
12. Miller SD, et al. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 1995;3:739-745.
13. Yu M, Johnson M, Tuohy VK. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J Exp Med 1996;183:1777-1788.
14. Voskuhl RR, Farris RW, Nagasato K, McFarland HF, Dubois Dalcq M. Epitope spreading occurs in active but not passive EAE induced by myelin basic protein. J Neuroimmunol 1996;70:103-111.
15. Samson MF, Smilek DE. Reversal of acute experimental autoimmune encephalomyelitis and prevention of relapses by treatment with a myelin basic protein peptide analogue modified to form long-lived peptide-MHC complexes. J Immunol 1995;155:2737-2746.
16. Vandenbark AA, Vainiene M, Arail K, Miller SD, Offner H. Prevention and treatment of relapsing autoimmune encephalomyelitis with myelin peptide coupled splenocytes. J Neurosci Res 1996;45:430-438.
17. Kennedy KJ, Smith WS, Miller SD, Karpus WJ. Induction of antigen-specific tolerance for the treatment of ongoing, relapsing autoimmune encephalomyelitis. J Immunol 1997;159:1036-1044.
18. Miller SD, et al. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat Med 1997;3:1133-1136.
19. Takács K, Douek DC, Altmann DM. Exacerbated autoimmunity associated with a T helper-1 cytokine profile shift in H-2E-transgenic mice. Eur J Immunol 1995;25:3134-3141.
20. Tuohy VK, Lu Z, Sobel RA, Laursen RA, Lees MB. Identification and characterization of a second encephalitogenic determinant of myelin proteolipid protein for SJL mice. J Immunol 1989;142:1523-1527.
21. Greer JM, Kuchroo VK, Sobel RA, Lees MJ. Identification and characterization of a second encephalitogenic determinant of myelin proteolipid protein (residues 178-191) for SJL mice. J Immunol 1992;149:783-788.
22. Touhy VK, Thomas DM. Sequence 104-117 of myelin proteolipid protein is a cryptic encephalitogenic T cell determinant for SJL/J mice. J Neuroimmunol 1995;56:161-170.
23. Sakai K, Zamvil SS, Mitchell DJ, Lim M, Rothbard JB, Steinman L. Characterization of a major encephalitogenic T cell epitope in SJL/J mice with synthetic oligopeptides of myelin basic protein. J Neuroimmunol 1988;19:21-32.
24. Burns J, Rosenzweig A, Zweiman B, Lisak RP. Isolation of myelin basic protein reactive T cells from normal human blood. Cell Immunol 1983;81:435-440.
25. Ota K, Matsui M, Milford E, Mackin GA, Weiner HL, Hader DA. T cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 1990;346:183-187.
26. Meinl E, et al. Myelin basic protein specific T lymphocyte repertoire in multiple sclerosis. J Clin Invest 1993;92:2633-2643.
27. Mustafa MI, Diener P, Hojeberg B, Van der Meide P, Olsson T. T cell immunity and interferon-gamma secretion during experimental allergic encephalomyelitis in Lewis rats. J Neuroimmunol 1991;31:165-177.
28. Mor F, Cohen I. Shifts in the epitopes of myelin basic protein recognized by Lewis rat T cells before, during, and after the induction of experimental autoimmune encephalomyelitis. J Clin Invest 1993;92:2199-2206.
29. Pender MP, Nguyen KB, McCombe PA, Kerr JFR. Apoptosis in the nervous system in experimental allergic encephalomyelitis. J Neurol Sci 1991;104:81-87.
30. Schmied M, et al. Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain. Am J Pathol 1993;143:446-452.
31. Zeine R, Owens T. Loss rather than downregulation of CD4+ T cells as a mechanism for remission from experimental allergic encephalomyelitis. J Neuroimmunol 1993;44:193-197.
32. Tabi Z, McCombe PA, Pender MP. Apoptotic elimination of Vb8.2 cells from the central nervous system during recovery from experimental autoimmune encephalomyelitis induced by the passive transfer of Vb8.2+ encephalitogenic T cells. Eur J Immunol 1994;24:2609-2617.
33. Ohmori K, Hong Y, Fujiwara M, Matsumoto Y. In situ demonstration of proliferating cells in the rat central nervous system during experimental autoimmune encephalomyelitis. Lab Invest 1992;66:54-62.
34. Matsumoto Y, Hanawa H, Tsuchida M, Abo T. In situ inactivation of infiltrating T cells in the central nervous system with autoimmune encephalomyelitis. The role of astrocytes. Immunology 1993;79:381-390.
35. Lindsey JW, Pappolla M, Steinman L. Reinduction of experimental autoimmune encephalomyelitis in mice. Cell Immunol 1995;162:235-240.
36. Lindsey JW Characteristics of initial and reinduced experimental autoimmune encephalomyelitis. Immunogenetics 1996;44:292-297.
37. Croft ML, Bradley M, Swain SL Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J Immunol 1994;152:2675-2685.
38. Lezzi G, Karjalainen K, Lanzavecchia A. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 1998;8:89-95.
39. McKenzie-Graham AJ, Pribyl TM, Kim S, Porte VR, Campagnoni AT, Voskhul RR. Myelin protein expression is increased in lymph nodes of mice with relapsing experimental autoimmune encephalomyelitis. J Immunol 1997;159:4602-4610.
40. Tough DF, Sprent J. Viruses and T cell turnover: evidence for bystander proliferation. Immunol Rev 1996;150:129-142.